Highlights and Quick Summary
- Operating Cash Flow Margin for the quarter ending September 30, 2022 was 0.0% (a NaN% decrease compared to previous quarter)
- Year-over-year quarterly Operating Cash Flow Margin decreased by NaN%
- Annual Operating Cash Flow Margin for 2021 was -7158.64% (a 45.28% increase from previous year)
- Annual Operating Cash Flow Margin for 2020 was -4927.64% (a 79.64% increase from previous year)
- Annual Operating Cash Flow Margin for 2019 was -2743.11% (a -24.03% decrease from previous year)
- Twelve month Operating Cash Flow Margin ending September 30, 2022 was 0.0% (a NaN% decrease compared to previous quarter)
- Twelve month trailing Operating Cash Flow Margin decreased by NaN% year-over-year
Trailing Operating Cash Flow Margin for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| 0.0% | 0.0% | -4295.63% | 0.0% |
Visit stockrow.com/BCEL
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Operating Cash Flow Margin of Atreca, Inc.
Most recent Operating Cash Flow Marginof BCEL including historical data for past 10 years.Interactive Chart of Operating Cash Flow Margin of Atreca, Inc.
Atreca, Inc. Operating Cash Flow Margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | 0.0% | 0.0% | -3406.8% | – |
| 2021 | 0.0% | -10160.13% | -3169.91% | -5144.77% | -7158.64% |
| 2020 | -4944.54% | -4243.34% | -3891.07% | -7754.98% | -4927.64% |
| 2019 | -4929.79% | 0.0% | 0.0% | 0.0% | -2743.11% |
| 2018 | – | 0.0% | 0.0% | 0.0% | -3610.82% |
| 2017 | – | – | – | – | -1459.92% |
Business Profile of Atreca, Inc.
Sector: Healthcare
Industry: Biotechnology